Osteosarcoma
📧 Sign up to get email alerts when something new happens for Osteosarcoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2025-01-15Clinical Trial Update: Natalizumab in Recurrent, Refractory or Progressive Pulmonary Metastatic Osteosarcoma [Phase 1, Phase 2]
The Phase 1/Phase 2 trial of natalizumab for pulmonary metastatic osteosarcoma has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-11-08Clinical Trial Update: BIO-11006 for Osteosarcoma and Ewing's Sarcoma Lung Metastases [Phase 2]
A Phase 2 study of BIO-11006 for metastatic osteosarcoma and metastatic Ewing's sarcoma with lung metastases has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-11-24Clinical Trial Update: A Vaccine Study for High Risk Cancers [Phase 1]
A Phase 1 cancer vaccine study has been withdrawn; it targeted neuroblastoma, rhabdomyosarcoma, and osteosarcoma.
-
CLINICAL_TRIALS withdrawal · 2017-07-02Clinical Trial Update: RO4929097 in Children With Relapsed/Refractory Solid or CNS Tumors, Lymphoma, or T-Cell Leukemia [Phase 1]
Phase 1 trial of RO4929097 in children with relapsed/refractory solid or CNS tumors, lymphoma, or T-cell leukemia has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-07-02Clinical Trial Update: A Phase I Study of Pazopanib as a Single Agent for Children With Refractory Solid Tumors [Phase 1]
A Phase I study of pazopanib as a single agent for children with refractory solid tumors has been withdrawn from the trial program.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2013-06-19Clinical Trial Update: Markers of Anthracycline-Related Cardiac Muscle Injury
The clinical trial NCT01112800 evaluating markers of anthracycline-related cardiac muscle injury in pediatric sarcoma patients has been with…
-
CLINICAL_TRIALS withdrawal · 2013-06-12Clinical Trial Update: Acupuncture Point Stimulation for Treatment of Chemotherapy Nausea and Vomiting [NA]
A pediatric clinical trial evaluating acupuncture point stimulation to prevent chemotherapy-induced nausea and vomiting has been withdrawn.